FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.
Abstract
FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.
Authors: Serilmez M, Abuelrub A, Erol I, Durdaği S
Journal: Turkish journal of biology = Turk biyoloji dergisi (2025)
DOI: 10.55730/1300…